Tanvex BioPharma, Inc. (TPE:6541)
Taiwan · Delayed Price · Currency is TWD 31.80
+0.20 (0.63%)
Sep 8, 2026, 1:30 PM CST
Tanvex BioPharma Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 592.56 | 878.71 | 376.96 | 380.75 | 786.23 | 2,223 |
Cash & Short-Term Investments | 592.56 | 878.71 | 376.96 | 380.75 | 786.23 | 2,223 |
Cash Growth | 3.78% | 133.11% | -1.00% | -51.57% | -64.63% | 7.46% |
Accounts Receivable | 144.65 | 67.32 | 0.07 | 9.4 | 0.33 | 2.52 |
Other Receivables | 81.93 | 89.3 | 31.58 | 27.43 | 27.36 | 25.31 |
Receivables | 226.58 | 156.62 | 31.65 | 36.83 | 27.69 | 27.84 |
Inventory | 331.68 | 420.71 | 217.84 | 108.29 | 170.84 | 90.33 |
Prepaid Expenses | 56.7 | 40.09 | 49.18 | 78.35 | 58.95 | 60.85 |
Other Current Assets | 1.36 | 1.06 | - | - | - | - |
Total Current Assets | 1,209 | 1,497 | 675.62 | 604.21 | 1,044 | 2,402 |
Property, Plant & Equipment | 2,745 | 2,761 | 1,827 | 1,928 | 2,151 | 2,114 |
Goodwill | 2,944 | 2,910 | - | - | - | - |
Other Intangible Assets | 462.1 | 485.32 | 7.07 | 3.38 | 12.07 | 10.17 |
Long-Term Deferred Tax Assets | 6.34 | 6.34 | - | - | - | - |
Other Long-Term Assets | 268.29 | 301.22 | 225.3 | 227.67 | 213.47 | 187.58 |
Total Assets | 7,635 | 7,961 | 2,735 | 2,763 | 3,420 | 4,714 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 19.07 | 102.99 | - | - | - | - |
Accrued Expenses | 142.1 | 147.64 | 134.27 | - | 115.93 | 137.49 |
Short-Term Debt | 135 | 30 | - | - | - | - |
Current Portion of Leases | 190.77 | 181.63 | 160.01 | 163.45 | 124.65 | 88.75 |
Current Income Taxes Payable | 26.89 | 26.89 | - | - | - | - |
Current Unearned Revenue | 171.83 | 79.3 | 11.11 | 6.91 | 28.07 | - |
Other Current Liabilities | 138.12 | 231.21 | 42.75 | 193.38 | 34.63 | 22.28 |
Total Current Liabilities | 823.78 | 799.66 | 348.14 | 363.73 | 303.29 | 248.51 |
Long-Term Debt | 459.98 | - | - | - | - | - |
Long-Term Leases | 1,298 | 1,367 | 1,488 | 1,568 | 1,715 | 1,670 |
Long-Term Unearned Revenue | 86 | 99 | 5.47 | 10.23 | - | - |
Other Long-Term Liabilities | 1.72 | 1.72 | - | - | 10.47 | - |
Total Liabilities | 2,669 | 2,267 | 1,842 | 1,942 | 2,028 | 1,919 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 2,650 | 2,649 | 1,641 | 1,340 | 3,527 | 3,525 |
Additional Paid-In Capital | 18,908 | 18,906 | 13,567 | 12,431 | 11,061 | 10,988 |
Retained Earnings | -16,408 | -15,637 | -14,136 | -12,755 | -12,969 | -11,327 |
Comprehensive Income & Other | -184.67 | -223.63 | -177.94 | -194.17 | -227.09 | -390.12 |
Shareholders' Equity | 4,966 | 5,694 | 893.31 | 821.11 | 1,391 | 2,795 |
Total Liabilities & Equity | 7,635 | 7,961 | 2,735 | 2,763 | 3,420 | 4,714 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 2,084 | 1,578 | 1,648 | 1,732 | 1,839 | 1,759 |
Net Cash (Debt) | -1,491 | -699.69 | -1,271 | -1,351 | -1,053 | 463.95 |
Net Cash Growth | - | - | - | - | - | -15.52% |
Net Cash Per Share | -5.68 | -2.86 | -8.19 | -10.48 | -8.95 | 4.27 |
Filing Date Shares Outstanding | 264.99 | 264.86 | 164.07 | 133.96 | 117.64 | 117.57 |
Total Common Shares Outstanding | 264.99 | 264.86 | 164.07 | 133.96 | 117.64 | 117.57 |
Working Capital | 385.09 | 697.52 | 327.48 | 240.48 | 740.43 | 2,153 |
Book Value Per Share | 18.74 | 21.50 | 5.44 | 6.13 | 11.83 | 23.77 |
Tangible Book Value | 1,559 | 2,298 | 886.24 | 817.73 | 1,379 | 2,785 |
Tangible Book Value Per Share | 5.88 | 8.68 | 5.40 | 6.10 | 11.73 | 23.68 |
Machinery | 1,179 | 1,126 | 1,089 | 982.54 | 975.18 | 889.53 |
Construction In Progress | 328.03 | 849.55 | 44.34 | 83.71 | 72.82 | 53.8 |
Leasehold Improvements | 1,104 | 517.23 | 509.94 | 415.69 | 388.62 | 318.95 |